For International Women’s Day (8 March), the Cambridge Festival (19 March – 4 April) is celebrating some of the remarkable contributions of women across diverse fields. From philosophy and music to AI and cosmology, the festival will highlight the pioneering work of women who have shaped our understanding of the world in profound ways.
Cambridge scientists have developed a urine test for early detection of lung cancer. The test, the first of its kind, detects ‘zombie’ cells that could indicate the first signs of the disease.
A pivotal clinical trial of a 'pill-on-a-thread' test, which will decide if it becomes a new screening programme for oesophageal cancer, has welcomed its first participants.
Today sees the launch of the Early Cancer Institute at Cambridge. Its mission is deceptively simple: to detect cancer early enough to cure it.
Find out about groundbreaking cancer research at Cambridge, including our planned new hospital, how we're studying the earliest stages of cancer, how AI is helping fight the disease, and the patients playing a key role in our work.
Ten outstanding Cambridge researchers have been elected as Fellows of the Royal Society, the UK’s national academy of sciences and the oldest science academy in continuous existence.
The University of Cambridge’s Early Cancer Institute – the UK's only research facility dedicated to understanding early cancer – has received a landmark £11 million donation to support its vital work in the fight against cancer.
A new test to help diagnose a condition that can lead to oesophageal cancer – developed by Cambridge researchers and trialled by the NHS – has reduced the need for invasive endoscopy in thousands of low-risk patients.
A man from Cambridge is the first to join the surveillance part of a clinical trial that could see routine screening for oesophageal cancer introduced into the NHS, potentially halving deaths from this cancer every year.
© 2025 University of Cambridge